Get the Stockscreener App
1.495
3.63%
-0.055
Omniab Inc stock is traded at $1.495, with a volume of 231.28K.
It is down -3.63% in the last 24 hours and down -8.36% over the past month.
OmniAb Inc offers therapeutic antibody discovery technologies. It focuses on enabling the rapid development of therapeutics by pushing the frontiers of drug discovery technologies. Its technology platform is designed to enable the efficient discovery of high-quality, fully human antibodies for a wide range of diseases. The heart of the OmniAb technology platform is the Biological Intelligence of its proprietary transgenic animals, including OmniRat, OmniMouse, and OmniChicken, that have been genetically modified to generate antibodies with human sequences which are naturally optimized through in vivo affinity maturation.
See More
Previous Close:
$1.55
Open:
$1.54
24h Volume:
231.28K
Relative Volume:
0.44
Market Cap:
$215.21M
Revenue:
$34.16M
Net Income/Loss:
$-50.62M
P/E Ratio:
-2.9429
EPS:
-0.508
Net Cash Flow:
$703.00K
1W Performance:
-6.06%
1M Performance:
-8.36%
6M Performance:
-14.65%
1Y Performance:
-64.27%
1-Day Range:
$1.48
$1.55
1-Week Range:
$1.45
$1.61
52-Week Range:
$1.22
$4.87
Omniab Inc Stock (OABI) Company Profile
Name
Omniab Inc
Sector
Industry
Phone
510-250-7800
Address
5980 HORTON STREET, EMERYVILLE
Compare OABI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OABI
Omniab Inc
|
1.495 | 223.13M | 34.16M | -50.62M | 703.00K | -0.508 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.62 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
641.93 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.49 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
823.27 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
184.13 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Omniab Inc Stock (OABI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-29-23 | Initiated | RBC Capital Mkts | Outperform |
| Apr-21-23 | Initiated | The Benchmark Company | Buy |
| Apr-13-23 | Initiated | Craig Hallum | Buy |
| Feb-22-23 | Initiated | Cowen | Outperform |
| Feb-13-23 | Initiated | H.C. Wainwright | Buy |
| Dec-20-22 | Initiated | Truist | Buy |
| Dec-16-22 | Initiated | Credit Suisse | Outperform |
| Nov-29-22 | Initiated | SVB Leerink | Outperform |
| Nov-28-22 | Initiated | Stifel | Buy |
View All
Omniab Inc Stock (OABI) Latest News
Risk vs reward if holding onto OmniAb Inc.Trade Exit Summary & Detailed Earnings Play Alerts - newser.com
What earnings revisions data tells us about OmniAb Inc.2025 Institutional Moves & Growth Focused Stock Pick Reports - newser.com
What To Expect From OmniAb Inc (OABI) Q3 2025 Earnings - GuruFocus
Does OmniAb Inc. qualify in momentum factor screeningJuly 2025 Pullbacks & Capital Protection Trading Alerts - newser.com
Is OmniAb Inc. stock bottoming outWeekly Stock Analysis & Technical Pattern Based Signals - newser.com
Will OmniAb Inc. Equity Warrant stock gain from government policies2025 Market Overview & Verified High Yield Trade Plans - newser.com
Why OmniAb Inc. stock remains on watchlistsWeekly Investment Summary & Accurate Trade Setup Notifications - newser.com
Visual trend scoring systems applied to OmniAb Inc.2025 Top Gainers & AI Enhanced Trading Alerts - newser.com
How high can OmniAb Inc. Equity Warrant stock goTrade Exit Summary & AI Forecast for Swing Trade Picks - newser.com
OmniAb Inc. Equity Warrant’s volatility index tracking explainedJuly 2025 Volume & Real-Time Stock Price Movement Reports - newser.com
How resilient is OmniAb Inc. stock in market downturnsJuly 2025 Short Interest & AI Optimized Trading Strategy Guides - newser.com
Will OmniAb Inc. stock benefit from upcoming earnings reportsRate Cut & Verified Momentum Stock Ideas - newser.com
Will OmniAb Inc. stock continue dividend increasesQuarterly Portfolio Report & Real-Time Market Sentiment Reports - newser.com
Published on: 2025-11-03 00:39:55 - newser.com
Developing predictive dashboards with OmniAb Inc. Equity Warrant dataJuly 2025 Short Interest & Weekly Breakout Watchlists - newser.com
Using data models to predict OmniAb Inc. Equity Warrant stock movementJuly 2025 Reactions & Community Supported Trade Ideas - newser.com
How to forecast OmniAb Inc. trends using time seriesDip Buying & Long-Term Safe Investment Ideas - newser.com
Applying Wyckoff theory to OmniAb Inc. stockWeekly Investment Summary & Safe Capital Growth Tips - newser.com
Should you wait for a breakout in OmniAb Inc.2025 Key Highlights & Entry Point Confirmation Alerts - newser.com
Exit strategy if you’re trapped in OmniAb Inc. Equity WarrantVolume Spike & Daily Growth Stock Tips - newser.com
Is OmniAb Inc. Equity Warrant stock ready for a breakoutWeekly Profit Analysis & Stepwise Entry and Exit Trade Signals - newser.com
How strong is OmniAb Inc. Equity Warrant stock balance sheetJuly 2025 Opening Moves & Reliable Price Action Trade Plans - newser.com
Momentum divergence signals in OmniAb Inc. chartJuly 2025 Sentiment & Safe Entry Point Alerts - newser.com
Does OmniAb Inc. show high probability of reboundWeekly Trend Summary & Advanced Swing Trade Entry Alerts - newser.com
What indicators show strength in OmniAb Inc. Equity WarrantJuly 2025 Spike Watch & Low Risk Profit Maximizing Plans - newser.com
Is OmniAb Inc. Equity Warrant stock a defensive play in 2025Weekly Market Outlook & Precise Buy Zone Tips - newser.com
Visualizing OmniAb Inc. stock with heatmapsPortfolio Value Summary & AI Forecasted Stock Moves - newser.com
Will OmniAb Inc. Equity Warrant stock deliver consistent dividendsJuly 2025 Action & Fast Entry and Exit Trade Plans - newser.com
Will OmniAb Inc. stock maintain dividend yield2025 Risk Factors & Consistent Growth Equity Picks - newser.com
Published on: 2025-11-01 02:02:38 - newser.com
Omniab Inc Stock (OABI) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.27%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):